Prime Medicine logo
Prime Medicine
PRME | NASDAQ
Chart Builder DCF Calculator
$4.19
-$0.08 (-1.87%)
At close: Nov 16, 2026, 4:00 PM ET
$4.29
+$0.10 (+2.36%)
After-hours: Nov 16, 2026, 7:46 PM ET

Prime Medicine Company Profile

Company profile explained

Company Profile

Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology. Central to their platform is the "Prime Editor" system, which combines a unique Prime Editor protein—a hybrid composed of a Cas protein and a reverse transcriptase enzyme—with a specialized pegRNA molecule. This pegRNA plays a crucial role by both guiding the Prime Editor to a precise location within the genome and providing the essential template for introducing the desired modification to the target DNA sequence. The company, founded in 2019, maintains its headquarters in Cambridge, Massachusetts.

Key Executives

Name Position
Allan Reine Chief Executive Officer & Director
Ryan E. Brown Chief Legal Officer
Svetlana Makhni Chief Financial Officer
Andrew Anzalone Co-Founder & Head of Platform
Ann L. Lee Chief Technical Officer
David R. Liu Co-Founder & Member of Scientific Advisory Board
Jeffrey D. Marrazzo Executive Chair
Matthew J. Hawryluk Chief Business Officer
Mohammed Asmal Chief Medical Officer
Niamh Alix Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Aug 06, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
Jul 08, 2026 8-K Current Report
Jun 08, 2026 4 Filing
Jun 08, 2026 4 Filing
Jun 08, 2026 4 Filing
Jun 08, 2026 4 Filing
Jun 08, 2026 4 Filing
Jun 08, 2026 4 Filing
Jun 08, 2026 4 Filing
View All SEC Filings ➞
Prime Medicine
Prime Medicine logo
Country United States
IPO Date Oct 20, 2022
Industry Biotechnology
Sector Healthcare
Employees 146
CEO Allan Reine

Contact Details

60 First Street Cambridge, Massachusetts 02141 United States

Stock Details

Ticker Symbol PRME
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001894562
CUSIP Number 74168J101
ISIN Number US74168J1016
SIC Code 2836

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.